(Total Views: 865)
Posted On: 08/07/2020 5:13:07 PM
Post# of 153886
I am a new investor in CYDY for a few months. Looking back, 350mg combo P3 trial was done in 2018 and the result is statitically significant, why does CYDY not have approval yet?
I know that FDA wants 700mg combo, but can they approve 350mg combo first then start another 700mg combo trial? FDA approved the P3 350mg combo trial, excellent result should warrant an approval.
This is the most significant sign I see that FDA is stalling us. Although NP is saying good thing about FDA so far, but CYDY's plan of application for 350mg HIV combo to UK approval shows NP's discontent about the delay by FDA in my opinion.
For the two trials for Covid, I haven't seen anything against FDA yet since CYDY does not have a chance to present clinical data yet. But slow walking by FDA is still a concern.
I know that FDA wants 700mg combo, but can they approve 350mg combo first then start another 700mg combo trial? FDA approved the P3 350mg combo trial, excellent result should warrant an approval.
This is the most significant sign I see that FDA is stalling us. Although NP is saying good thing about FDA so far, but CYDY's plan of application for 350mg HIV combo to UK approval shows NP's discontent about the delay by FDA in my opinion.
For the two trials for Covid, I haven't seen anything against FDA yet since CYDY does not have a chance to present clinical data yet. But slow walking by FDA is still a concern.
(2)
(0)
